"You decide and we provide."
Cart 0

Loxo's targeted drug helps variety of advanced cancers in small study

reutersCOMPANYNEWS companyNews

June 3 (Reuters) - Three quarters of patients with a wide variety of advanced cancers responded to a Loxo Oncology Inc therapy that targets a specific genetic defect, according to data from a small study presented on Saturday at the year's most important oncology meeting.

Older Post Newer Post

Leave a comment

Please note, comments must be approved before they are published